Investigation of Nicotianamine and 2′ Deoxymugineic Acid as Enhancers of Iron Bioavailability in Caco-2 Cells

被引:9
|
作者
Beasley, Jesse T. [1 ]
Hart, Jonathan J. [2 ]
Tako, Elad [2 ]
Glahn, Raymond P. [2 ]
Johnson, Alexander A. T. [1 ]
机构
[1] Univ Melbourne, Sch BioSci, Melbourne, Vic 3010, Australia
[2] USDA ARS, Robert W Holley Ctr Agr & Hlth, Ithaca, NY 14853 USA
来源
NUTRIENTS | 2019年 / 11卷 / 07期
基金
美国农业部;
关键词
biofortification; iron deficiency anemia; iron absorption; ferritin; ascorbic acid; epicatechin; RAY-FLUORESCENCE MICROSCOPY; WHEAT; AVAILABILITY; LOCALIZATION; POLYPHENOLS; ABSORPTION; NUTRITION; ANEMIA; FLOUR; ZINC;
D O I
10.3390/nu11071502
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Nicotianamine (NA) is a low-molecular weight metal chelator in plants with high affinity for ferrous iron (Fe2+) and other divalent metal cations. In graminaceous plant species, NA serves as the biosynthetic precursor to 2 ' deoxymugineic acid (DMA), a root-secreted mugineic acid family phytosiderophore that chelates ferric iron (Fe3+) in the rhizosphere for subsequent uptake by the plant. Previous studies have flagged NA and/or DMA as enhancers of Fe bioavailability in cereal grain although the extent of this promotion has not been quantified. In this study, we utilized the Caco-2 cell system to compare NA and DMA to two known enhancers of Fe bioavailability-epicatechin (Epi) and ascorbic acid (AsA)-and found that both NA and DMA are stronger enhancers of Fe bioavailability than Epi, and NA is a stronger enhancer of Fe bioavailability than AsA. Furthermore, NA reversed Fe uptake inhibition by Myricetin (Myr) more than Epi, highlighting NA as an important target for biofortification strategies aimed at improving Fe bioavailability in staple plant foods.
引用
收藏
页数:12
相关论文
共 50 条
  • [21] MANIPULATION AND MEASUREMENT OF STORAGE IRON IN CACO-2 CELLS
    GANGLOFF, MB
    GLAHN, RP
    MILLER, DD
    NORVELL, WA
    VANCAMPEN, DR
    FASEB JOURNAL, 1995, 9 (04): : A984 - A984
  • [22] Uptake of iron from ferritin by Caco-2 cells
    Lonnerdal, B
    Kelleher, SL
    Theil, EC
    FASEB JOURNAL, 2004, 18 (05): : A767 - A767
  • [23] Iron treatment and human intestinal Caco-2 cells
    Beard, J
    AMERICAN JOURNAL OF CLINICAL NUTRITION, 2000, 72 (03): : 677 - 678
  • [24] The use of solubility, dialyzability, and Caco-2 cell methods to predict iron bioavailability
    Fairweather-Tait, Susan
    Phillips, Ian
    Wortley, Gary
    Harvey, Linda
    Glahn, Ray
    INTERNATIONAL JOURNAL FOR VITAMIN AND NUTRITION RESEARCH, 2007, 77 (03) : 158 - 165
  • [25] CACO-2 CELLS AS A MODEL FOR STUDYING MINERAL BIOAVAILABILITY - EFFECTS OF INOSITOL PHOSPHATES ON THE ABSORPTION OF IRON AND ZINC
    HILL, AD
    HAN, O
    FAILLA, ML
    HOPKINS, R
    MORRIS, ER
    SMITH, JC
    FASEB JOURNAL, 1993, 7 (03): : A306 - A306
  • [26] Cytotoxicity of absorption enhancers in Caco-2 cell monolayers
    Sakai, M
    Imai, T
    Ohtake, H
    Otagiri, M
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 1998, 50 (10) : 1101 - 1108
  • [27] Bioavailability of genistein, daidzein, and their glycosides in intestinal epithelial Caco-2 cells
    Steensma, A
    Noteborn, HPJM
    van der Jagt, RCM
    Polman, THG
    Mengelers, MJB
    Kuiper, HA
    ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY, 1999, 7 (03) : 209 - 211
  • [28] Effects of various absorption enhancers on transport of clodronate through Caco-2 cells
    Raiman, J
    Törmälehto, S
    Yritys, K
    Junginger, HE
    Mönkkönen, J
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2003, 261 (1-2) : 129 - 136
  • [29] TANDEM MASS-SPECTROMETRIC INVESTIGATION OF THE PHYTOSIDEROPHORES MUGINEIC ACID, DEOXYMUGINEIC ACID AND NICOTIANAMINE
    KENNY, PTM
    NOMATO, K
    ANALYST, 1994, 119 (05) : 891 - 895